Global Ovotransferrin Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Ovotransferrin Market Research Report 2024
Ovotransferrin is a glycoprotein of egg white albumen. It has a molecular weight of 76,000 daltons and contains about 700 amino acids. Ovotransferrin makes up approximately 13% of egg albumen (in contrast to ovalbumin, which comprises 54%). As a member of the transferrin and metalloproteinase family, ovotransferrin has been found to possess antibacterial and antioxydant and immunomodulatory properties, arising primarily through its iron (Fe3+) binding capacity by locking away a key biochemical component necessary for micro-organismal survival. Bacteria starved of iron are rendered incapable of moving, making ovotransferrin a potent bacteriostatic.
According to Mr Accuracy reports’s new survey, global Ovotransferrin market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ovotransferrin market research.
Key manufacturers engaged in the Ovotransferrin industry include Bachem, Bioseutica, Thomas Scientific, ICL, Inc., Neova Technologies, Inc. and Dunn Labortechnik GmbH, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Ovotransferrin were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Ovotransferrin market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ovotransferrin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Bachem
Bioseutica
Thomas Scientific
ICL, Inc.
Neova Technologies, Inc.
Dunn Labortechnik GmbH
Segment by Type
Metal-Free Ovotransferrin
Metal-Bound Ovotransferrin
Anti-Osteoporotic
Cardiovascular Disease
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Ovotransferrin report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Ovotransferrin market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ovotransferrin market research.
Key manufacturers engaged in the Ovotransferrin industry include Bachem, Bioseutica, Thomas Scientific, ICL, Inc., Neova Technologies, Inc. and Dunn Labortechnik GmbH, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Ovotransferrin were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Ovotransferrin market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ovotransferrin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
Bachem
Bioseutica
Thomas Scientific
ICL, Inc.
Neova Technologies, Inc.
Dunn Labortechnik GmbH
Segment by Type
Metal-Free Ovotransferrin
Metal-Bound Ovotransferrin
Segment by Application
Anti-Osteoporotic
Cardiovascular Disease
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Ovotransferrin report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
